{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:19:26Z","timestamp":1792318766218,"version":"4.4.0"},"reference-count":288,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010188"],"award-info":[{"award-number":["2023A1515010188"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515010183"],"award-info":[{"award-number":["2020A1515010183"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227347"],"award-info":[{"award-number":["8227347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972262"],"award-info":[{"award-number":["81972262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MedComm"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Cancer is a significant challenge to society and public health in the 21st century. According to GLOBOCAN 2020, there were 19.3 million new cancer cases with approximately 10.0 million deaths in 2020 globally. By 2040, 28 million new cases and 16.2 million deaths are estimated. With the escalating challenges of cancer and limitations of conventional therapies like surgery, chemotherapy, and radiotherapy, the development of novel therapies such as immunotherapy and targeted therapy is required. Immunotherapy, especially immune checkpoint inhibitors (ICIs), has become a significant advancement in cancer treatment, combating tumors by activating the immune system. This review offers a thorough overview of ICIs, including their classification, mechanisms of action, and adverse events. It also examines the application of ICIs across various cancer types especially on advanced or unresectable malignancies, such as head and neck squamous cell carcinoma, esophageal cancer, non\u2010small cell lung cancer, breast cancer, hepatocellular carcinoma, and bladder cancer, highlighting their therapeutic potential and the challenges they face. By providing a comprehensive analysis, this review aims to construct a reference system for clinicians to better understand and utilize ICIs in treating cancer.<\/jats:p>","DOI":"10.1002\/mco2.70176","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T07:18:48Z","timestamp":1754810328000},"source":"Crossref","is-referenced-by-count":12,"title":["Application of Immune Checkpoint Inhibitors in Cancer"],"prefix":"10.1002","volume":"6","author":[{"given":"Zhijun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Biliary\u2010Pancreatic Surgery Sun Yat\u2010sen Memorial Hospital Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Liver Surgery Sun Yat\u2010Sen University Cancer Center Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichen","family":"Den","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Sun Yat\u2010Sen University Cancer Center Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery Sun Yat\u2010Sen University Cancer Center Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Han","sequence":"additional","affiliation":[{"name":"Breast Tumor Center Sun Yat\u2010Sen University Cancer Center Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhang","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Urology Sun Yat\u2010Sen University Cancer Center Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Biliary\u2010Pancreatic Surgery Sun Yat\u2010sen Memorial Hospital Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Ning","sequence":"additional","affiliation":[{"name":"Department of Biliary\u2010Pancreatic Surgery Sun Yat\u2010sen Memorial Hospital Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinHui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery First People's Hospital of Foshan  Foshan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Biliary\u2010Pancreatic Surgery Sun Yat\u2010sen Memorial Hospital Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biliary\u2010Pancreatic Surgery Sun Yat\u2010sen Memorial Hospital Sun Yat\u2010sen University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01856-7"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08809-3"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/328267a0"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5256.1734"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/70932"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm730"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/11594010-000000000-00000"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0712"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0087"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01325-0"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.101"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01979-x"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-4070"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683419"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.343"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.27.5223"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113365"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0277-x"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.05.001"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-024-10184-9"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02902-0"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00345-8"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01827-8"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009662"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/857519"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.2.166"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.205"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002535"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1748982"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10327-7"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd2712"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.192461099"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-024-00586-9"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02023-w"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03869-1"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.08.048"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx286"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217100"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009399"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.06.014"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.706133"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.08.004"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01569-z"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02877-z"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.06.036"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.07.016"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01499-1"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg6752"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp7302"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4746"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0261"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07121-9"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-2455"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00226-1"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.11.002"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005829"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1311658"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004424"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1079"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1715715"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00224-3"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.12.017"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100649"},{"key":"e_1_2_11_68_1","first-page":"1","article-title":"Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future Considerations","volume":"42","author":"Nenclares P.","year":"2022","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30066-3"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31999-8"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30421-7"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-1695"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3351"},{"key":"e_1_2_11_75_1","volume-title":"KEYNOTE\u2010689: Phase 3 Study of Adjuvant and Neoadjuvant Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma","author":"Uppaluri R.","year":"2019"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.783"},{"key":"e_1_2_11_78_1","volume-title":"Neoadjuvant Nivolumab (N) plus Weekly Carboplatin (C) and Paclitaxel (P) in Resectable Locally Advanced Head and Neck Cancer","author":"Zinner R.","year":"2020"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02510-2"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0666"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2955"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26472-9"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002485"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-022-01293-9"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00136-4"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3849"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02275-x"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2024.01.016"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33080-8"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.6038"},{"key":"e_1_2_11_91_1","volume-title":"TACTI\u2010003: A Randomized Phase IIb Study of Eftilagimod Alpha (soluble LAG\u20103 protein) and Pembrolizumab as First\u2010line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","author":"Adkins D.","year":"2022"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01363"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.40"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1535"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13176"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9846"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032125"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01234-4"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00797-2"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.02.009"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.02.007"},{"key":"e_1_2_11_102_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068714","article-title":"Sintilimab versus Placebo in Combination with Chemotherapy as First Line Treatment for Locally Advanced or Metastatic Oesophageal Squamous Cell Carcinoma (ORIENT\u201015): Multicentre, Randomised, Double Blind, Phase 3 Trial","volume":"377","author":"Lu Z.","year":"2022","journal-title":"BMJ"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00108-0"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01926"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.12836"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34176"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00060-8"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0969"},{"key":"e_1_2_11_109_1","volume-title":"SKYSCRAPER\u201007: A Phase III, Randomized, Double\u2010blind, Placebo\u2010controlled Study of Atezolizumab with or without Tiragolumab in Patients with Unresectable ESCC Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy","author":"Goodman K. A.","year":"2022"},{"key":"e_1_2_11_110_1","volume-title":"SKYSCRAPER\u201008: A Phase III, Randomized, Double\u2010blind, Placebo\u2010controlled Study of First\u2010line (1L) Tiragolumab (tira)+ Atezolizumab (atezo) and Chemotherapy (CT) in Patients (pts) with Esophageal Squamous Cell Carcinoma (ESCC)","author":"Hsu C.\u2010H.","year":"2024"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01888"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026982"},{"key":"e_1_2_11_113_1","first-page":"63","article-title":"The Additional Exclusions of ROS1 Fusions (In Addition to EGFR Mutation and ALK Fusions) in the Cemiplimab NSCLC FDA Indication (EMPOWER\u2010Lung 1 and \u2010Lung 3). Catching up with Current Scientific View of Immunotherapy in Never\u2010Smoker Predominant Actionable Driver Mutation Positive NSCLC?","volume":"14","author":"Brazel D.","year":"2023","journal-title":"Lung Cancer (Auckl)"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-017-0308-6"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2016.02.001"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32409-7"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.06.019"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00329-7"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01281-7"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32517-X"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30167-6"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03136"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01990"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.07.009"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01503"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.2027"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1894"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS9152"},{"key":"e_1_2_11_130_1","article-title":"Datopotamab Deruxtecan versus Docetaxel for Previously Treated Advanced or Metastatic Non\u2013small Cell Lung Cancer: The Randomized, Open\u2010label Phase III TROPION\u2010Lung01 Study","author":"Ahn M.\u2010J.","year":"2024","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.215"},{"key":"e_1_2_11_132_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-021-00833-4"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4756"},{"key":"e_1_2_11_134_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8931"},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4224"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809615"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0023"},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549"},{"key":"e_1_2_11_139_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6650"},{"key":"e_1_2_11_140_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02772"},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30465-4"},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.2310"},{"key":"e_1_2_11_143_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3452"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.610149"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.05.035"},{"key":"e_1_2_11_146_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1029"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30324-7"},{"key":"e_1_2_11_148_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl3649"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2084"},{"key":"e_1_2_11_150_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01850-7"},{"key":"e_1_2_11_151_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00171"},{"key":"e_1_2_11_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.022"},{"key":"e_1_2_11_153_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_2_11_154_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-NB2017-138"},{"key":"e_1_2_11_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"e_1_2_11_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.047"},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.026"},{"key":"e_1_2_11_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00604-5"},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01307"},{"key":"e_1_2_11_160_1","doi-asserted-by":"publisher","DOI":"10.1159\/000515553"},{"key":"e_1_2_11_161_1","doi-asserted-by":"publisher","DOI":"10.1159\/000535338"},{"key":"e_1_2_11_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30011-5"},{"key":"e_1_2_11_163_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2022.2022121"},{"key":"e_1_2_11_164_1","doi-asserted-by":"publisher","DOI":"10.1159\/000527175"},{"key":"e_1_2_11_165_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.4003"},{"key":"e_1_2_11_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.03.033"},{"key":"e_1_2_11_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.003"},{"key":"e_1_2_11_168_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3275"},{"key":"e_1_2_11_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00252-7"},{"key":"e_1_2_11_170_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010534"},{"key":"e_1_2_11_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00326-6"},{"key":"e_1_2_11_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00469-2"},{"key":"e_1_2_11_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00961-3"},{"key":"e_1_2_11_174_1","volume-title":"Camrelizumab Plus Rivoceranib vs Sorafenib as First\u2010Line Therapy for Unresectable Hepatocellular Carcinoma (uHCC): Final Overall Survival Analysis of the Phase 3 CARES\u2010310 Study","author":"Vogel A.","year":"2024"},{"key":"e_1_2_11_175_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46542-y"},{"issue":"1","key":"e_1_2_11_176_1","first-page":"395","article-title":"Combination of GT90001 and Nivolumab in Patients With Advanced Hepatocellular Carcinoma: A Multicenter, Single\u2010arm, Phase 1b\/2 Study","volume":"21","author":"Hsu C.","year":"2023","journal-title":"BMC Medicine [Electronic Resource]"},{"key":"e_1_2_11_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03857-5"},{"key":"e_1_2_11_178_1","volume-title":"EMERALD\u20101: A Phase 3, Randomized, Placebo\u2010Controlled Study of Transarterial Chemoembolization Combined With Durvalumab With or Without Bevacizumab in Participants With Unresectable Hepatocellular Carcinoma Eligible for Embolization","author":"Lencioni R.","year":"2024"},{"key":"e_1_2_11_179_1","volume-title":"PD\u20101 Inhibitor (sintilimab) and Lenvatinib plus TACE\u2010HAIC as Conversion Therapy for Initially Unresectable HCC: A Single\u2010arm, Phase 2 Clinical Trial (PLATIC)","author":"Yuan Y.","year":"2024"},{"key":"e_1_2_11_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2024.02.007"},{"key":"e_1_2_11_181_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3949"},{"key":"e_1_2_11_182_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17168"},{"key":"e_1_2_11_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00305-8"},{"key":"e_1_2_11_184_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad331"},{"key":"e_1_2_11_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.07.005"},{"key":"e_1_2_11_186_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01663-6"},{"key":"e_1_2_11_187_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02745"},{"key":"e_1_2_11_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109881"},{"key":"e_1_2_11_189_1","volume-title":"Nivolumab (NIVO) Plus Ipilimumab (IPI) vs Lenvatinib (LEN) or Sorafenib (SOR) as First\u2010Line Treatment for Unresectable Hepatocellular Carcinoma (uHCC): First Results From CheckMate 9DW","author":"Galle P. R.","year":"2024"},{"key":"e_1_2_11_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.02.005"},{"key":"e_1_2_11_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2278"},{"key":"e_1_2_11_192_1","article-title":"Pharmacological Activation of STAT1\u2010GSDME Pyroptotic Circuitry Reinforces Epigenetic Immunotherapy for Hepatocellular Carcinoma","author":"Tu Y.","year":"2024","journal-title":"Gut"},{"key":"e_1_2_11_193_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12607"},{"key":"e_1_2_11_194_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202403629"},{"key":"e_1_2_11_195_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010157"},{"key":"e_1_2_11_196_1","article-title":"Combination CXCR4 and PD1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses against Hepatocellular Carcinoma","author":"Morita S.","year":"2024","journal-title":"Cancer Immunology Research"},{"key":"e_1_2_11_197_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0627"},{"key":"e_1_2_11_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.05.050"},{"key":"e_1_2_11_199_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137201"},{"key":"e_1_2_11_200_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.04.013"},{"key":"e_1_2_11_201_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64273-5"},{"key":"e_1_2_11_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00147-9"},{"key":"e_1_2_11_203_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01148"},{"key":"e_1_2_11_204_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0628-7"},{"key":"e_1_2_11_205_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034442"},{"key":"e_1_2_11_206_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00004-8"},{"key":"e_1_2_11_207_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002788"},{"key":"e_1_2_11_208_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32455-2"},{"key":"e_1_2_11_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00152-2"},{"key":"e_1_2_11_210_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683"},{"key":"e_1_2_11_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30065-7"},{"key":"e_1_2_11_212_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.6795"},{"key":"e_1_2_11_213_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1525"},{"key":"e_1_2_11_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.09.013"},{"key":"e_1_2_11_215_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.6_suppl.439"},{"key":"e_1_2_11_216_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.4580"},{"key":"e_1_2_11_217_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1085-z"},{"key":"e_1_2_11_218_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309863"},{"key":"e_1_2_11_219_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3571"},{"key":"e_1_2_11_220_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01643"},{"key":"e_1_2_11_221_1","volume-title":"Study RC48\u2010C014: Preliminary Results of RC48\u2010ADC Combined with toripalimab in Patients with Locally Advanced or Metastatic Urothelial Carcinoma","author":"Zhou L.","year":"2022"},{"key":"e_1_2_11_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.04.002"},{"key":"e_1_2_11_223_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3923"},{"key":"e_1_2_11_224_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703481"},{"key":"e_1_2_11_225_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16405"},{"key":"e_1_2_11_226_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_2_11_227_1","first-page":"211","article-title":"Immune Related Adverse Events Associated with Anti\u2010CTLA\u20104 Antibodies: Systematic Review and Meta\u2010analysis","volume":"13","author":"Bertrand A.","year":"2015","journal-title":"BMC Medicine [Electronic Resource]"},{"key":"e_1_2_11_228_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_2_11_229_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k793"},{"key":"e_1_2_11_230_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0779-6"},{"key":"e_1_2_11_231_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2669"},{"key":"e_1_2_11_232_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1396752"},{"key":"e_1_2_11_233_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-1012-5"},{"key":"e_1_2_11_234_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3844"},{"key":"e_1_2_11_235_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00126-1"},{"key":"e_1_2_11_236_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3915"},{"key":"e_1_2_11_237_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.41165"},{"key":"e_1_2_11_238_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3699"},{"key":"e_1_2_11_239_1","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13752"},{"key":"e_1_2_11_240_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3545"},{"key":"e_1_2_11_241_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2"},{"key":"e_1_2_11_242_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02568-y"},{"key":"e_1_2_11_243_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01055"},{"key":"e_1_2_11_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.05.801"},{"key":"e_1_2_11_245_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0779-5"},{"key":"e_1_2_11_246_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01462"},{"key":"e_1_2_11_247_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809697"},{"key":"e_1_2_11_248_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00082-2"},{"key":"e_1_2_11_249_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109970"},{"key":"e_1_2_11_250_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.02.080"},{"key":"e_1_2_11_251_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03250-w"},{"issue":"4","key":"e_1_2_11_252_1","article-title":"FDA Approves Nivolumab plus Ipilimumab for the Treatment of Advanced HCC","volume":"34","author":"Wright K.","year":"2020","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_11_253_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009061"},{"key":"e_1_2_11_254_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1611"},{"key":"e_1_2_11_255_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1496427"},{"key":"e_1_2_11_256_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.01.021"},{"key":"e_1_2_11_257_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009742"},{"key":"e_1_2_11_258_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-025-10783-w"},{"key":"e_1_2_11_259_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508512"},{"key":"e_1_2_11_260_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaf008"},{"key":"e_1_2_11_261_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528084"},{"key":"e_1_2_11_262_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-025-10246-6"},{"key":"e_1_2_11_263_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115252"},{"key":"e_1_2_11_264_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008950"},{"key":"e_1_2_11_265_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010680"},{"key":"e_1_2_11_266_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010114"},{"key":"e_1_2_11_267_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.325652"},{"key":"e_1_2_11_268_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115221"},{"key":"e_1_2_11_269_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20232079"},{"key":"e_1_2_11_270_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.01.004"},{"key":"e_1_2_11_271_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009704"},{"key":"e_1_2_11_272_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1516524"},{"key":"e_1_2_11_273_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.11.014"},{"key":"e_1_2_11_274_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.12.051"},{"key":"e_1_2_11_275_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115170"},{"key":"e_1_2_11_276_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-021-09957-3"},{"key":"e_1_2_11_277_1","article-title":"Cancer and Treatment Specific Incidence Rates of Immune\u2010related Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review","author":"Jayathilaka B.","year":"2024","journal-title":"British Journal of Cancer"},{"key":"e_1_2_11_278_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101621"},{"key":"e_1_2_11_279_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0066"},{"key":"e_1_2_11_280_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00870-6"},{"key":"e_1_2_11_281_1","article-title":"Neutralizing GDF\u201015 Can Overcome Anti\u2010PD\u20101 and Anti\u2010PD\u2010L1 Resistance in Solid Tumours","author":"Melero I.","year":"2024","journal-title":"Nature"},{"key":"e_1_2_11_282_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006270"},{"key":"e_1_2_11_283_1","article-title":"Cancer Immunotherapeutic Challenges from Autophagy\u2010immune Checkpoint Reciprocal Regulation","author":"Zhang G.","year":"2024","journal-title":"Trends in Cancer"},{"key":"e_1_2_11_284_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02894-y"},{"key":"e_1_2_11_285_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009543"},{"key":"e_1_2_11_286_1","article-title":"Ubiquitination of CD47 Regulates Innate Anti\u2010Tumor Immune Response","author":"Gou Q.","year":"2024","journal-title":"Advanced Science"},{"key":"e_1_2_11_287_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02179-5"},{"key":"e_1_2_11_288_1","article-title":"Targeting ATM Enhances Radiation Sensitivity of Colorectal Cancer by Potentiating Radiation\u2010induced Cell Death and Antitumor Immunity","author":"Xie Y.","year":"2024","journal-title":"Journal of Advanced Research"},{"key":"e_1_2_11_289_1","article-title":"Targeting piRNA\u2010137463 Inhibits Tumor Progression and Boosts Sensitivity to Immune Checkpoint Blockade via De Novo Cholesterol Biosynthesis in Lung Adenocarcinoma","author":"Zhan Y.","year":"2024","journal-title":"Advanced Science"}],"container-title":["MedComm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mco2.70176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T06:14:29Z","timestamp":1755324869000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mco2.70176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":288,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/mco2.70176"],"URL":"https:\/\/doi.org\/10.1002\/mco2.70176","archive":["Portico"],"relation":{},"ISSN":["2688-2663","2688-2663"],"issn-type":[{"value":"2688-2663","type":"print"},{"value":"2688-2663","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"article-number":"e70176"}}